Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare Biotechnology
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd > current institutional holdings for fsd pharma
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(137)
•••
Comment by DavidRosenbergon Nov 18, 2021 4:02pm
66 Views
Post# 34142664

RE:RE:current institutional holdings for fsd pharma

RE:RE:current institutional holdings for fsd pharma
Mil_Man54 wrote: Look at you Rosenberg with a blatant attempt at trying to mislead investors again.....you see, if you looked at the actual data at that link...you would that out of the 23 institutional investors 13 have either 1000 shares or less, have 0 shares value or have sold out.....and of the remaining 10, only one has over $100K in share value and the rest dwindle down from $69K to $1K in value.....for a total percentage 0.80% institutional investment......maybe you should actuially look closely at the data before you embarrass yourself by cher picking the info.....because when you look at it......this is meaningless......







Look how you are twisting the words around i didnt say anything all i did was share the link

you are deceptive towards real fsd pharma shareholders short position troll to the max
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities